Clinical Application of CNS-Acting Agents in FSD

While the recent data supporting the therapeutic use of centrally acting agents as a monotherapy for FSD are cautiously encouraging, there would seem to be tremendous promise for these centrally acting compounds to be integrated with treatment approaches that utilize other pathways in a multilayered, individualized approach to care. Perelman MA. Clinical application of CNS-acting agents in FSD.